Ekso Bionics Holdings (EKSO) Cash from Investing Activities (2016 - 2025)
Ekso Bionics Holdings has reported Cash from Investing Activities over the past 12 years, most recently at -$126000.0 for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 500.0% to -$126000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$188000.0, a 408.11% decrease, with the full-year FY2025 number at -$188000.0, down 408.11% from a year prior.
- Cash from Investing Activities reached -$126000.0 in Q4 2025 per EKSO's latest filing, down from -$12000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $1000.0 in Q4 2021, with the low at -$5.0 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$30500.0 (2024), against an average of -$396857.1.
- Peak YoY movement for Cash from Investing Activities: crashed 503500.0% in 2022, then surged 99.15% in 2023.
- Tracing EKSO's Cash from Investing Activities over 5 years: stood at $1000.0 in 2021, then crashed by 503500.0% to -$5.0 million in 2022, then surged by 99.15% to -$43000.0 in 2023, then soared by 51.16% to -$21000.0 in 2024, then tumbled by 500.0% to -$126000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$126000.0, -$12000.0, and -$40000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.